← Back to guidelines
Cardiology60 papers

Chronic ischemic heart disease

Last edited: 4/15/2026

Overview

Chronic ischemic heart disease (CICD) is a prevalent condition characterized by reduced blood flow to the heart muscle, leading to significant morbidity and mortality worldwide. Management involves multifaceted strategies aimed at reducing cardiovascular risk and improving patient outcomes 1.

Diagnosis

  • Clinical History: Presence of typical angina symptoms, history of myocardial infarction, or ischemic ECG changes.
  • Electrocardiography (ECG): Evidence of ischemia or previous infarction.
  • Echocardiography: Assessment of left ventricular function and wall motion abnormalities.
  • Coronary Angiography: Definitive diagnosis and assessment of coronary artery disease severity 1.
  • Management

  • Pharmacotherapy:
  • - ACE Inhibitors: Recommended for symptom relief and prevention of future cardiovascular events 1. - Beta-Blockers: Used to reduce myocardial oxygen demand and improve survival 1. - Aspirin: Antiplatelet therapy to prevent thrombotic events 1. - Statins: To manage cholesterol levels and reduce cardiovascular risk 1.
  • Lifestyle Modifications: Smoking cessation, dietary changes, exercise, and weight management.
  • Special Populations

  • Renal Dysfunction: Hypertensive patients with chronic ischemic heart disease and renal impairment require careful blood pressure control (<130/80 mmHg) to prevent further kidney damage 2.
  • Elderly: Older patients are at higher risk for adverse outcomes; management should consider comorbidities like chronic kidney disease and peripheral revascularisation 1.
  • Key Recommendations

  • Regular monitoring and maintenance of guideline-directed medical therapy, including ACE inhibitors, beta-blockers, and aspirin, to reduce mortality and hospitalization (Evidence: Strong 1).
  • Intensive blood pressure control, particularly in patients with renal dysfunction, aiming for <130/80 mmHg (Evidence: Moderate 2).
  • Tailored management in elderly patients, focusing on age-related risk factors such as chronic kidney disease and peripheral vascular disease (Evidence: Expert opinion 1).
  • References

    1 Komajda M, Kerneis M, Tavazzi L, Balanescu S, Cosentino F, Cremonesi A et al.. The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up. European journal of preventive cardiology 2018. link 2 Barrios V, Escobar C, Murga N, de Pablo C, Bertomeu V, Calderón A et al.. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. Journal of hypertension 2008. link

    Original source

    1. [1]
      The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up.Komajda M, Kerneis M, Tavazzi L, Balanescu S, Cosentino F, Cremonesi A et al. European journal of preventive cardiology (2018)
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG